This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 99/9/996    most recent 01.RES.0000247932.71270.2cv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Matkovich, S. J. Articles by Dorn, G. W. Search for Related Content PubMed PubMed Citation Articles by Matkovich, S. J. Articles by Dorn, G. W., II Related Collections Cell signalling/signal transduction Genetically altered mice Heart failure - basic studies

(Circulation Research. 2006;99:996.)
© 2006 American Heart Association, Inc.

Integrative Physiology

Cardiac-Specific Ablation of G-Protein Receptor Kinase 2 Redefines Its Roles in Heart Development and ß-Adrenergic Signaling

Scot J. Matkovich, Abhinav Diwan, Justin L. Klanke, Daniel J. Hammer, Yehia Marreez, Amy M. Odley, Eric W. Brunskill, Walter J. Koch, Robert J. Schwartz, Gerald W. Dorn, II

From the Center for Molecular Cardiovascular Research (S.J.M., A.D., J.L.K., D.J.H., Y.M., A.M.O., E.W.B., G.W.D.), University of Cincinnati, Ohio; Center for Translational Medicine (W.J.K.), Jefferson Medical College, Philadelphia, Pa; and Institute of Biosciences and Technology (R.J.S.), Texas A&M University Health Science Center, Houston.

Correspondence to Gerald W Dorn II, MD, Hanna Professor and Director, Molecular Cardiovascular Research, 231 Albert Sabin Way, ML 0839, Cincinnati, OH 45267-0839. E-mail dorngw{at}ucmail.uc.edu

G-protein receptor kinase 2 (GRK2) is 1 of 7 mammalian GRKs that phosphorylate ligand-bound 7-transmembrane receptors, causing receptor uncoupling from G proteins and potentially activating non–G-protein signaling pathways. GRK2 is unique among members of the GRK family in that its genetic ablation causes embryonic lethality. Cardiac abnormalities in GRK2 null embryos implicated GRK2 in cardiac development but prevented studies of the knockout phenotype in adult hearts. Here, we created GRK2-loxP–targeted mice and used Cre recombination to generate germline and cardiac-specific GRK2 knockouts. GRK2 deletion in the preimplantation embryo with EIIa-Cre (germline null) resulted in developmental retardation and embryonic lethality between embryonic day 10.5 (E10.5) and E11.5. At E9.5, cardiac myocyte specification and cardiac looping were normal, but ventricular development was delayed. Cardiomyocyte-specific ablation of GRK2 in the embryo with Nkx2.5-driven Cre (cardiac-specific GRK2 knockout) produced viable mice with normal heart structure, function, and cardiac gene expression. Cardiac-specific GRK2 knockout mice exhibited enhanced inotropic sensitivity to the ß-adrenergic receptor agonist isoproterenol, with impairment of normal inotropic and lusitropic tachyphylaxis, and exhibited accelerated development of catecholamine toxicity with chronic isoproterenol treatment. These findings show that cardiomyocyte autonomous GRK2 is not essential for myocardial development after cardiac specification, suggesting that embryonic developmental abnormalities may be attributable to extracardiac effects of GRK2 ablation. In the adult heart, cardiac GRK2 is a major factor regulating inotropic and lusitropic tachyphylaxis to ß-adrenergic agonist, which likely contributes to its protective effects in catecholamine cardiomyopathy.

Key Words: ß-adrenergic receptor • G protein–coupled receptor kinase • recombination • contractility • isoproterenol • desensitization

This article has been cited by other articles:

				X. Jiang, P. Yang, and L. Ma Kinase activity-independent regulation of cyclin pathway by GRK2 is essential for zebrafish early development PNAS, June 23, 2009; 106(25): 10183 - 10188. [Abstract] [Full Text] [PDF]

				D. R. Fermin, A. Barac, S. Lee, S. P. Polster, S. Hannenhalli, T. L. Bergemann, S. Grindle, D. B. Dyke, F. Pagani, L. W. Miller, et al. Sex and Age Dimorphism of Myocardial Gene Expression in Nonischemic Human Heart Failure Circ Cardiovasc Genet, December 1, 2008; 1(2): 117 - 125. [Abstract] [Full Text] [PDF]

				M. Philipp, G. B. Fralish, A. R. Meloni, W. Chen, A. W. MacInnes, L. S. Barak, and M. G. Caron Smoothened Signaling in Vertebrates Is Facilitated by a G Protein-coupled Receptor Kinase Mol. Biol. Cell, December 1, 2008; 19(12): 5478 - 5489. [Abstract] [Full Text] [PDF]

				H. I. Cohn, D. M. Harris, S. Pesant, M. Pfeiffer, R.-H. Zhou, W. J. Koch, G. W. Dorn 2nd, and A. D. Eckhart Inhibition of vascular smooth muscle G protein-coupled receptor kinase 2 enhances {alpha}1D-adrenergic receptor constriction Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1695 - H1704. [Abstract] [Full Text] [PDF]

				P. W. Raake, L. E. Vinge, E. Gao, M. Boucher, G. Rengo, X. Chen, B. R. DeGeorge Jr, S. Matkovich, S. R. Houser, P. Most, et al. G Protein-Coupled Receptor Kinase 2 Ablation in Cardiac Myocytes Before or After Myocardial Infarction Prevents Heart Failure Circ. Res., August 15, 2008; 103(4): 413 - 422. [Abstract] [Full Text] [PDF]

				L. E. Vinge, P. W. Raake, and W. J. Koch Gene Therapy in Heart Failure Circ. Res., June 20, 2008; 102(12): 1458 - 1470. [Abstract] [Full Text] [PDF]

				J.-Y. Qian, P. Harding, Y. Liu, E. Shesely, X.-P. Yang, and M. C. LaPointe Reduced Cardiac Remodeling and Function in Cardiac-Specific EP4 Receptor Knockout Mice With Myocardial Infarction Hypertension, February 1, 2008; 51(2): 560 - 566. [Abstract] [Full Text] [PDF]

				A. Diwan, J. Wansapura, F. M. Syed, S. J. Matkovich, J. N. Lorenz, and G. W. Dorn II Nix-Mediated Apoptosis Links Myocardial Fibrosis, Cardiac Remodeling, and Hypertrophy Decompensation Circulation, January 22, 2008; 117(3): 396 - 404. [Abstract] [Full Text] [PDF]

				G. W. Dorn II The Fuzzy Logic of Physiological Cardiac Hypertrophy Hypertension, May 1, 2007; 49(5): 962 - 970. [Full Text] [PDF]